Schrödinger to Participate in Upcoming Investor Conferences
February 24 2025 - 7:30AM
Business Wire
Schr�dinger (Nasdaq: SDGR) today announced that management will
participate in the following conferences in March:
- TD Cowen 45th Annual Health Care Conference: Fireside
chat on Tuesday, March 4, 2025 at 10:30 a.m. E.T.
- Leerink Partners Global Biopharma Conference 2025:
Fireside chat on Monday, March 10, 2025 at 3:40 p.m. E.T.
- KBCM Healthcare Forum: Fireside chat on Tuesday, March
18, 2025 at 9:00 a.m. E.T.
The live discussions can be accessed in the “Investors” section
of Schr�dinger’s website and will be archived for approximately 90
days following the event.
About Schr�dinger
Schr�dinger is transforming molecular discovery with its
computational platform, which enables the discovery of novel,
highly optimized molecules for drug development and materials
design. Schr�dinger’s software platform is built on more than 30
years of R&D investment and is licensed by biotechnology,
pharmaceutical and industrial companies, and academic institutions
around the world. Schr�dinger also leverages the platform to
advance a portfolio of collaborative and proprietary programs and
is advancing three clinical-stage oncology programs. Founded in
1990, Schr�dinger has approximately 900 employees operating from 15
locations globally. To learn more, visit www.schrodinger.com,
follow us on LinkedIn and Instagram, or visit our blog,
Extrapolations.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250224832431/en/
Allie Nicodemo Schr�dinger, Inc. allie.nicodemo@schrodinger.com
617-356-2325
Schrodinger (NASDAQ:SDGR)
Historical Stock Chart
From Mar 2025 to Apr 2025
Schrodinger (NASDAQ:SDGR)
Historical Stock Chart
From Apr 2024 to Apr 2025